GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » HTG Molecular Diagnostics Inc (OTCPK:HTGMQ) » Definitions » Shiller PE Ratio

HTG Molecular Diagnostics (HTG Molecular Diagnostics) Shiller PE Ratio : (As of May. 21, 2024)


View and export this data going back to 2015. Start your Free Trial

What is HTG Molecular Diagnostics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


HTG Molecular Diagnostics Shiller PE Ratio Historical Data

The historical data trend for HTG Molecular Diagnostics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HTG Molecular Diagnostics Shiller PE Ratio Chart

HTG Molecular Diagnostics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

HTG Molecular Diagnostics Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of HTG Molecular Diagnostics's Shiller PE Ratio

For the Diagnostics & Research subindustry, HTG Molecular Diagnostics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HTG Molecular Diagnostics's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, HTG Molecular Diagnostics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where HTG Molecular Diagnostics's Shiller PE Ratio falls into.



HTG Molecular Diagnostics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

HTG Molecular Diagnostics's E10 for the quarter that ended in Mar. 2023 is calculated as:

For example, HTG Molecular Diagnostics's adjusted earnings per share data for the three months ended in Mar. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-2.28/127.3478*127.3478
=-2.280

Current CPI (Mar. 2023) = 127.3478.

HTG Molecular Diagnostics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201212 0.000 96.871 0.000
201309 0.000 98.790 0.000
201312 -1,787.580 98.326 -2,315.203
201403 -1,966.570 99.695 -2,512.058
201406 -2,583.630 100.560 -3,271.890
201409 -2,299.640 100.428 -2,916.066
201412 -2,737.590 99.070 -3,518.998
201503 -133.593 99.621 -170.775
201506 -311.398 100.684 -393.865
201509 -136.799 100.392 -173.531
201512 -149.399 99.792 -190.652
201603 -183.599 100.470 -232.715
201606 -176.399 101.688 -220.911
201609 -165.599 101.861 -207.034
201612 -136.799 101.863 -171.025
201703 -131.399 102.862 -162.678
201706 -107.999 103.349 -133.077
201709 -82.800 104.136 -101.256
201712 -27.000 104.011 -33.058
201803 -39.600 105.290 -47.896
201806 -25.200 106.317 -30.185
201809 -30.600 106.507 -36.588
201812 -12.600 105.998 -15.138
201903 -34.200 107.251 -40.609
201906 -30.600 108.070 -36.059
201909 -27.000 108.329 -31.740
201912 -13.601 108.420 -15.975
202003 -15.240 108.902 -17.821
202006 -15.600 108.767 -18.265
202009 -13.440 109.815 -15.586
202012 -9.960 109.897 -11.542
202103 -9.600 111.754 -10.940
202106 -4.680 114.631 -5.199
202109 -7.200 115.734 -7.922
202112 -8.300 117.630 -8.986
202203 -9.730 121.301 -10.215
202206 -6.480 125.017 -6.601
202209 -4.920 125.227 -5.003
202212 -4.120 125.222 -4.190
202303 -2.280 127.348 -2.280

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


HTG Molecular Diagnostics  (OTCPK:HTGMQ) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


HTG Molecular Diagnostics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of HTG Molecular Diagnostics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


HTG Molecular Diagnostics (HTG Molecular Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
3430 E. Global Loop, Tucson, AZ, USA, 85706
HTG Molecular Diagnostics Inc is a commercial-stage RNA platform-based life sciences company focused on advancing the promise of precision medicine. Its proprietary NGS-adapted chemistry and HTG EdgeSeq platform automates sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets using a relatively small amount of biological samples, in liquid or solid forms. Its products include instruments, consumables, and software that combine to form its HTG EdgeSeq platform. The company's menu of HTG EdgeSeq molecular profiling panels is automated on its HTG EdgeSeq platform, applying genomic sequencing tools to quickly generate gene expression data using its simplified workflow for customers.
Executives
Stephen Barat officer: Senior VP of Therapeutics C/O HTG MOLECULAR DIAGNOSTICS, INC., 3430 E. GLOBAL LOOP, TUCSON AZ 85706
Thomas W. Dubensky director C/O ADURO BIOTECH, INC., 740 HEINZ AVENUE, BERKELEY CA 94710
L5 Capital Inc. 10 percent owner 1 FIRST CANADIAN PLACE, 39TH FLOOR, TORONTO A6 M5X 1H3
Christopher P Kiritsy director
Byron Lawson officer: SVP/Chief Commercial Officer C/O HTG MOLECULAR DIAGNOSTICS, INC., 3430 E. GLOBAL LOOP, TUCSON AZ 85706
Tim B Johnson director, officer: President & CEO
Laurence W Lytton 10 percent owner 467 CENTRAL PARK WEST, NY NY 10025
Laura Lee Godlewski officer: VP of Accounting and Reporting C/O HTG MOLECULAR DIAGNOSTICS, INC., 3430 E. GLOBAL LOOP, TUCSON AZ 85706
Michelle Renee Griffin director 19723 NE 65TH LANE, KIRKLAND WA 98033
Shaun D Mcmeans officer: VP, Finance & Admin. & CFO 3708 E COLUMBIA STREET, SUITE #110, TUCSON AZ 85714-3413
Novo Holdings A/s 10 percent owner TUBORG HAVNEVEJ 19, HELLERUP G7 2900
Plc Glaxosmithkline 10 percent owner 980 GREAT WEST ROAD, BRENTFORD MIDDLESEX X0 TW8 9GS
Nv Qiagen 10 percent owner HULSTERWEG 82, PL VENLO P7 5912
Ann Hanham director ONE EMBRACADERO CTR, STE 2700, SAN FRANCISCO CA 94111
Don M Hardison director

HTG Molecular Diagnostics (HTG Molecular Diagnostics) Headlines